Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001628280-25-059045

President and COO acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohlhepp Ryan President and COO 2025-12-26 Option exercise +25,000 $4.44 $110,923 214,141 D
Derivatives
Cohlhepp Ryan President and COO 2025-12-26 Option exercise · Stock Option (Right to Buy) −25,000 39,909 D
Loading xslF345X05/wk-form4_1767046687.xml…